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Objectives. We sought to assess baroreflex function in patients
with hypertrophic cardiomyopathy (HCM).
Background. We have previously demonstrated a specific ab-
normality in the afferent limb of the cardiopulmonary baroreflex
in patients with vasovagal syncope. Patients with HCM exhibit
abnormal control of their vasculature during exercise and upright
tilt; we therefore hypothesize a similar abnormality in the afferent
limb of the cardiopulmonary baroreflex arc.
Methods. We investigated 29 patients with HCM and 32 control
subjects. Integrated baroreceptor sensitivity was assessed after
administration of phenylephrine. Cardiopulmonary baroreceptor
sensitivity was assessed by measuring forearm vascular resistance
(FVR) during lower body negative pressure (LBNP). Carotid
artery baroreflex sensitivity was assessed by measuring the in RR
interval during manipulation of carotid artery transmural pres-
sure. The integrity of the efferent limb of the reflex arc was
determined by studying responses to both handgrip and periph-
eral alpha-receptor sensitivity.
Results. During LBNP, FVR increased by only 2.36 6 9 U in
patients, compared with an increase of 12.3 6 8.76 U in control
subjects (p 5 0.001). FVR paradoxically fell in eight patients, but
in none of the control subjects. Furthermore, FVR fell by 4.9 6
5.6 U in patients with a history of syncope, compared with an
increase of 4.7 6 7.2 U in those without syncope (p 5 0.014).
Integrated and carotid artery baroreflex sensitivities were similar
in patients and control subjects (14 6 7 vs. 14 6 6 ms/mm Hg, p 5
NS and 23 6 2 vs. 24 6 2 ms/mm Hg, p 5 NS, respectively).
Similarly, handgrip responses and the dose/response ratio to
phenylephrine were not significantly different.
Conclusions. This study suggests that patients with HCM have
a defect in the afferent limb of the cardiopulmonary reflex arc.
(J Am Coll Cardiol 1998;31:1377–82)
©1998 by the American College of Cardiology
We previously reported (1,2) that exercise hypotension occurs
in ;30% of patients with hypertrophic cardiomyopathy
(HCM) as a result of an exaggerated fall in systemic vascular
resistance. This is associated with impaired forearm vaso-
constriction or paradoxic vasodilation during dynamic leg
exercise (1,2). A possible mechanism is exaggerated activa-
tion of left ventricular (LV) mechanoreceptors during exer-
cise.
This observation may be clinically important when consid-
ered in light of a recent prospective study showing an associ-
ation between abnormal blood pressure responses to exercise
and an increased risk of sudden death in young patients (,25
years) with HCM (3). One group has also reported a high
incidence of syncope and hypotension during tilt-table testing
in HCM (4). Activation of ventricular mechanoreceptors in the
setting of a small hypercontractile ventricle has been proposed
as a mechanism of vasovagal syncope during tilt-table testing
(5). Patients with HCM typically have relatively small LV
cavities and increased LV ejection fractions.
There is evidence of an abnormality in the autonomic
control of the cardiovascular system in patients with HCM.
One group reported reduced heart rate variability during deep
breathing and a decreased Valsalva ratio in patients with HCM
compared with control subjects (where the Valsalva ratio is
defined as the ratio of the longest RR interval after the
maneuver to the shortest before the maneuver) (6). Studies
assessing heart rate variability in patients with HCM have
yielded conflicting results (7–9). We assessed integrated
baroreceptor sensitivity, cardiopulmonary sensitivity and
carotid artery baroreflex sensitivity in control subjects and
patients with HCM. Using a similar protocol, we recently
demonstrated a specific abnormality of cardiopulmonary
baroreceptor function in patients with vasovagal syncope
(10), located in the afferent limb of the reflex arc. We
hypothesised that patients with HCM would have a similar
abnormality.
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Methods
Patients. Thirty-six consecutive patients with HCM were
selected from the Cardiomyopathy Clinic at the Royal Bris-
bane Hospital. The diagnosis of HCM was based on typical
clinical, echocardiographic and hemodynamic features (11).
Two-dimensional echocardiography was used to determine LV
hypertrophy (.1.4 cm) in the absence of cardiac or systemic
disease that could have caused such hypertrophy. Patients were
excluded from the study 1) if blood pressure exceeded
160/90 mm Hg, 2) if there was a definite history or clinical
suspicion of autonomic failure; or 3) if the cardiac rhythm was
other than sinus. Twenty-nine patients satisfied these criteria
and consented to take part in the study (Table 1).
Thirty-two approximately age- and gender-matched control
subjects with no history of cardiovascular disease and normal
clinical examinations (electrocardiography and echocardiogra-
phy) were recruited (Table 1). These control subjects were
found in the endoscopy data base of the Department of
Gastroenterology.
Study protocol. The investigations were performed at the
Royal Brisbane Hospital with the hospital’s Ethical Committee
approval. Written informed consent was obtained from all
patients and control subjects. Subjects arrived at 8 AM having
fasted from midnight. All cadioactive medications were with-
drawn for at least five half-lives before the study, with the
exception of amiodarone, which was continued in three pa-
tients. Patients and control subjects were randomly tested and
fully familiarized with the protocol before initiation of each
study. All participants rested for 30 min between studies.
Assessment of baroreceptor sensitivity. The assessment of
cardiopulmonary, integrated and carotid artery baroreceptor
sensitivities entailed recording the electrocardiogram and mea-
suring blood pressure using a Finapress recorder (Ohmeda
2300, Anglewood). Both these signals and all physiologic
variables recorded were acquired using the Acq Knowledge
data acquisition program (Biopac Systems) on an Apple
Macintosh IICI computer.
Cardiopulmonary baroreceptor sensitivity. Cardiopu-
monary baroreflex sensitivity was assessed in all patients and in
a subset of 18 control subjects. Cardiopulmonary receptors
were deactivated by reducing central venous pressure. This was
achieved by application of a mild lower body negative pressure
(LBNP, 215 mm Hg) using a LBNP device. The blood
pressure and heart rate were effectively unaltered by the mild
negative pressure. This stimulus is believed to evoke forearm
vasoconstriction predominantly through unloading of LV
mechanoreceptors (12). Cardiopulmonary baroreceptor sensi-
tivity was assessed during application of LBNP (215 mm Hg)
after stabilization for 2 min. The pressure within the lower
body box was measured by a transducer (Dwyer [series 602]
differential pressure transmitter integrated with Innotech cur-
rent sensing controller and display). The following variables
were measured both at rest and during LBNP: 1) Forearm
blood flow was measured by a standard mercury-in-silastic
strain gauge plethysmography technique (Hokanson) (13) and
calculated from the mean of three slopes. 2) Forearm vascular
resistance (FVR) was calculated as the quotient of the mean
arterial pressure (mm Hg) and forearm blood flow (ml/min per
100 ml) and expressed in resistance units. 3) Central venous
pressure was recorded using a Baxter transducer (Baxter
Health Care Corp.) through a central line inserted from the
antecubital vein.
Relation of cardiopulmonary sensitivity to LV outflow tract
gradient. A subgroup of seven patients was studied during
application of 215 mm Hg LBNP to determine whether
dynamic increases in the LV outflow tract gradient might be
responsible for activation of cardiopulmonary baroreceptors.
We assessed changes in the LV outflow tract gradient, LV
dimensions and fractional shortening. Two patients had a rest
mean Doppler outflow tract gradient .20 mm Hg and com-
plete systolic anterior motion of the mitral valve; two had
Abbreviations and Acronyms
FVR 5 forearm vascular resistance
HCM 5 hypertrophic cardiomyopathy
LBNP 5 lower body negative pressure
LV 5 left ventricular
Table 1. Clinical Characteristics of Patients With Hypertrophic
Cardiomyopathy (n 5 29) and Control Subjects (n 5 32)
Age (yr)
Patients 43 6 18
Control subjects 42 6 17
Men/women
Patients 11/18
Control subjects 8/24
Family history of HCM 17 (59%)
Family history of sudden death 6 (21%)
Concentric/asymmetrical septal hypertrophy 7 (37%)
NYHA functional class
I 11
II 17
III 1
Syncope 7 (24%)
Presyncope 16 (55%)
Typical chest pain 10 (34%)
Atypical chest pain 5 (17%)
Palpitations 3 (10%)
LV wall thickness (mm) 23.2 6 8.3
LV diastolic dimension (mm) 40.3 6 13.1
LV systolic dimension (mm) 25.4 6 8.8
Left atrial dimension (mm) 39.7 6 12.0
Fractional shortening (%) 44.4 6 8.3
Mean gradient .20 mm Hg 6 (21%)
Complete SAM of mitral valve 7 (24%)
Incomplete SAM of mitral valve 8 (28%)
NSVT/rate (beats/min) 7 (24%)/134 6 34
Data presented are mean value 6 SD or number (%) of patients with
hypertrophic cardiomyopathy. HCM 5 hypertrophic cardiomyopathy; LV 5 left
ventricular; NSVT 5 nonsustained ventricular tachycardia; NYHA 5 New York
Heart Association; SAM 5 systolic anterior motion.
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incomplete systolic anterior motion of the mitral valve but no
significant outflow tract gradient; and three had no systolic
anterior motion of the mitral valve or outflow tract gradient.
Integrated baroreceptor sensitivity. Integrated barorecep-
tor sensitivity was assessed using a standard phenylephrine
ramp method (14). In brief, phenylephrine was injected into an
antecubital vein at a dose sufficient to progressively increase
systolic blood pressure by ;20 to 30 mm Hg, and hence
increase the activity of the arterial baroreceptors. This induced
a linearly related lengthening of the RR interval, which
allowed the slope of the linear regression of the RR interval
versus systolic blood pressure to be taken as the baroreflex
sensitivity during baroreceptor stimulation.
The phenylephrine dose was given three times to increase
the systolic blood pressure by 30 mm Hg. The three measure-
ments of baroreceptor sensitivity were calculated, and the
mean value represented phenylephrine baroreceptor sensitiv-
ity.
Carotid artery baroreceptor sensitivity. Carotid artery
baroreceptor sensitivity was measured using a standard tech-
nique (15). In brief, the patients were fitted with a lead collar
connected to an air source. This permitted the application of
negative and positive pressures around the neck, increasing
and decreasing carotid artery transmural pressure and selec-
tively stimulating and inhibiting carotid artery baroreceptors,
respectively. The negative and positive pressures were ran-
domly applied in six separate steps ranging from 250 to
50 mm Hg. Each pressure was applied only once during
end-expiration held for 10 s. The maximal change in the RR
interval over three beats, immediately after application of neck
pressure, represented the reflex response for that applied
pressure. The slope of the linear regression of the RR intervals
versus applied neck pressures was taken as the carotid artery
baroreflex sensitivity.
Responses to handgrip and phenylephrine. To assess
whether the vasoconstrictor response to alpha-adrenergic stim-
ulation is impaired in patients with HCM, we assessed the
blood pressure response to the alpha1 agonist phenylephrine in
patients and control subjects. In brief, phenylephrine was
injected into an antecubital vein. The dose of phenylephrine
required to produce an increase in systolic blood pressure of
;30 mm Hg was divided by the patient’s weight to give a
weight-adjusted dose/response ratio.
To assess whether reflex responses to other pressor maneu-
vers were impaired in patients with HCM, the response of
diastolic blood pressure to handgrip was assessed in patients
and control subjects. Handgrip was maintained at 30% of the
maximal voluntary contraction up to a maximum of 5 min,
using a handgrip dynamometer, and blood pressure was mea-
sured each minute. The difference between baseline blood
pressure and blood pressure immediately before release of
handgrip was taken as the measure of response.
Data analysis. Results are expressed as the mean value 6
SD. The data were normally distributed. Statistical analysis was
performed using paired and unpaired t tests and the chi-square
test where appropriate. A p value ,0.05 was considered
significant.
Results
Cardiopulmonary baroreceptor sensitivity. In the patient
group, FVR increased from 39.7 6 16.9 to 40.5 6 16.3 U
during 215 mm Hg LBNP, compared with an increase from
36 6 12.0 to 47.7 6 18.1 U during 215 mm Hg LBNP in the
control group (p 5 0.001) (Table 2 and Fig. 1). This related to
a decrease in forearm blood flow from 2.53 6 0.8 to 2.01 6
0.6 ml/min during 15 mm Hg LBNP in the control group
compared with a decrease from 2.46 6 0.9 to 2.37 6
1.08 ml/min during 15 mm Hg LBNP in the patient group (p 5
0.01). Data from one patient were excluded owing to a
decrease in systolic blood pressure .5 mm Hg during LBNP.
In eight patients there was a paradoxic fall in FVR during
LBNP, a response seen in none of the control subjects. Heart
rate did not change during LBNP in either group (66.3 6 9.3
beats/min at rest vs. 66.4 6 10.3 beats/min during LBNP in
patients compared with 65.4 6 10.2 beats/min at rest vs. 68.5 6
12.7 beats/min during LBNP in control subjects). Similarly,
there were no changes in blood pressure during LBNP in
either group (80.4 6 11.7 mm Hg at rest vs. 82.7 6 13.1 mm Hg
at 215 mm Hg LBNP in patients compared with 84.8 6
13.8 mm Hg at rest and 86.4 6 14.5 mm Hg at 215 mm Hg
LBNP in control subjects). The change in central venous
Table 2. Baroreflex Sensitivities in Patients With Hypertrophic
Cardiomyopathy Versus Control Subjects
Patients
Control
Subjects
p
Value
CPG (mm Hg) 2.1 6 7.9 13.7 6 10.7 0.0001
Integrated gain (ms/mm Hg) 14 6 7 14 6 6 NS
Carotid artery BRS (ms/mm Hg) 23 6 2 24 6 2 NS
Data presented are mean value 6 SD. BRS 5 baroreflex sensitivity; CPG 5
cardiopulmonary gain at 215 mm Hg lower body negative pressure.
Figure 1. Change in FVR evoked by application of 215 mm Hg
LBNP. Overall, patients demonstrated less marked constriction than
control subjects and, in some cases, paradoxical vasodilation.
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pressure (rest compared with LBNP) was similar in both the
patient and control groups (4 6 4 vs. 4 6 4 mm Hg, p 5 NS).
Although cardioactive medications were withdrawn for five
half-lives before the study, the possibility of a beta-blocker
withdrawal effect was considered. When three patients who
had been taking beta-blockers (propranolol, 100 mg, and
metoprolol, 50 mg) before enrollment in the study were
removed from the analysis, there was still a significant differ-
ence between the change in FVR in the patients and that in
control subjects (2.4 6 8.2 vs. 13.7 6 10.7 U, p 5 0.001).
Relation of cardiopulmonary sensitivity to LV outflow tract
gradient and echocardiographic data. When comparing pa-
tients with a significant LV outflow tract (mean Doppler
gradient .20 mm Hg) and those without it, there was no
significant difference in the change in FVR between the two
groups (3.1 6 7.4 vs. 1.2 6 8.7 U, p 5 NS). When the patients
were classified into those with a significant outflow tract
gradient or complete or incomplete systolic anterior motion of
the mitral valve leaflets, or both, and those remaining, again
there was no significant difference between the two groups
(3.1 6 8.1 vs. 1.5 6 8.2 U, p 5 NS).
Assessment was made of LV outflow tract gradients and LV
end-diastolic measurements at rest and during application of
215 mm Hg LBNP in a subgroup of seven patients. Of the two
patients with a significant rest LV outflow tract gradient
(.20 mm Hg), the gradient increased in both patients (from 42
to 58 mm Hg and from 34 to 39 mm Hg). One of these patients
exhibited normal forearm vasoconstriction and one exhibited
forearm vasodilation during LBNP. Of the five patients with-
out a significant outflow tract gradient (,20 mm Hg), none
developed a significant outflow tract gradient during applica-
tion of LBNP. There were no significant changes in LV
end-diastolic dimensions during LBNP in any of the patients
(46 6 8 mm at rest vs. 44 6 6 mm during LBNP, p 5 NS).
Similarly, there were no changes when comparing systolic
dimensions at rest (2.76 6 0.92 cm) with those during LBNP
(2.58 6 0.58 cm) and fractional shortening at rest (45 6 8%)
with that during LBNP (43 6 9%).
Relation of paradoxic forearm vasodilation during LBNP
to clinical syncope or presyncope. Paradoxic vasodilation dur-
ing LBNP was associated with a clinical history of syncope.
Although paradoxic vasodilation occurred in five of seven
patients with a history of syncope, vasoconstriction occurred in
17 of 22 patients without a history of syncope (chi-square 5.6,
p 5 0.02).
Relation of FVR to age and LV wall thickness. There was
no correlation between a patient’s percent change in FVR and
either maximal LV wall thickness (r 5 0.33) or age (r 5 0.11).
Integrated and carotid artery baroreceptor sensitivities.
Integrated and carotid artery baroreceptor sensitivities were
similar in patients and control subjects (14 6 7 vs. 14 6 6
ms/mm Hg, p 5 NS and 23 6 2 vs. 24 6 2 ms/mm Hg, p 5
NS) (Table 2).
Responses to handgrip and phenylephrine. The increase in
diastolic blood pressure during handgrip was similar in patients
and control subjects (18 6 8 vs. 22 6 10 mm Hg, p 5 NS). The
phenylephrine dose/response ratio was also similar (3.2 6 2.0
vs. 3.9 6 2.0 mm Hg/kg body weight per mg phenylephrine, p 5
NS).
Discussion
Exercise hypotension is common in patients with HCM
(1,2) and is associated with an increased risk of sudden death
(3). It is due to an exaggerated fall in systemic vascular
resistance, postulated to be related to profound activation of
LV mechanoreceptors (1,2). To date, there has been no
definite evidence of dysfunction of these receptors in patients
with HCM.
This study has shown that patients with HCM have 1) either
impaired forearm vasoconstriction or paradoxic vasodilation
during application of subhypotensive LBNP, compared with
age-matched control subjects; 2) a normal response both to
handgrip and pressor response to alpha1-adrenergic stimula-
tion; and 3) integrated and carotid artery baroreceptor sensi-
tivities similar to those of control subjects. These data, as will
be discussed, suggest a dysfunction of cardiopulmonary (prin-
cipally LV) mechanoreceptors during central blood volume
unloading in patients with HCM. Mechanosensitive receptors
located in the ventricles, atria and great veins (cardiopulmo-
nary receptors), aortic arch and carotid sinus are normally
tonically active. Carotid artery afferent fibers are carried in the
glossopharyngeal nerve and cardiopulmonary and aortic arch
afferent fibers in the vagus nerve to the brain stem. This tonic
activity restrains sympathetic efferent activity and increases
vagal afferent activity. Increased pressure further increases
baroreceptor firing (causing vasodilation and bradycardia),
and reduced pressure causes decreased firing, with the oppo-
site effects (Fig. 2).
The rationale for the widespread use of subhypotensive
LBNP to assess cardiopulmonary baroreceptor function is the
belief that the attendant reduction in preload reduces tonic LV
(and other cardiopulmonary) mechanoreceptor firing with a
minimal influence on carotid artery and aortic arch mechano-
receptor firing. Although blood pressure does not fall during
application of up to 220 mm Hg LBNP, changes in stroke
volume may nevertheless alter the rate of change of pressure
(dP/dt) and influence carotid artery baroreceptor function.
Human studies suggest that cardiopulmonary baroreceptor
inactivation is the principal cause of forearm vasoconstriction
during subhypotensive LBNP (12,16), even though there may
also be some carotid artery baroreflex inhibition. The obser-
vation of markedly impaired forearm vasoconstriction in heart
transplant recipients suggests that LV mechanoreceptors are
more important than other cardiopulmonary receptors in this
response (17).
Reduced cardiopulmonary baroreceptor sensitivity in pa-
tients with HCM. Our data suggest that during subhypoten-
sive central blood volume unloading induced by application of
215 mm Hg LBNP, there is reduced inactivation or increased
paradoxic activation, or both, of cardiopulmonary barorecep-
tors in patients with HCM. Paradoxic vasodilator responses
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were associated with a clinical history of syncope. There was no
relation between impaired cardiopulmonary baroreceptor sen-
sitivity and rest LV outflow tract gradient. We observed that
215 mm Hg LBNP did not provoke LV outflow tract gradients
in patients without rest gradients, and furthermore did not
significantly reduce LV diastolic dimension. These observa-
tions suggest that dynamic LV outflow tract gradients are
unlikely to be an important mechanism of the abnormal FVR
seen in most patients.
Our data suggest that the site of the abnormality of the
cardiopulmonary baroreceptor reflex is probably in the afferent
limb of the cardiac baroreflex (due to either a primary abnor-
mality of the baroreceptors or local ventricular wall stresses).
The observation of normal integrated and carotid artery
baroreceptor function in patients with HCM suggests it is
unlikely that the central processing of these baroreflex signals
is abnormal. The normal response to handgrip implies that
central command and skeletal metaboreceptor reflex arcs are
intact. The normal pressor response to phenylephrine in
patients with HCM implies that there is no impairment of
peripheral responsiveness to alpha-adrenergic stimulation.
Taken together, these data suggest that arterial baroreflex
mechanisms, central processing and the efferent limb of the
cardiac baroreflex are probably intact. Gilligan et al. (6) have
previously reported a reduced Valsalva ratio and reduced
heart rate variability during deep breathing in patients with
HCM. The mechanism of this paradoxic activation of LV
mechanoreceptors is conjecture. Myocyte disarray, which is
associated with abnormal desmosome disposition (18), may
result in marked focal abnormalities of LV wall stress, result-
ing in activation of these receptors. The possibility of a primary
abnormality of the receptors cannot be excluded.
It is possible that abnormal local LV wall stresses, during
both exercise and central hypovolemia, may be responsible for
LV mechanoreceptor activation. This might be due to abnor-
mal cardiac morphology. The development or exacerbation of
LV outflow tract gradients during LBNP might be contributory
in some cases, but our data suggest this is not an important
mechanism. We have reported that similar abnormal reflex
responses occur during exercise and during central hypovole-
mia in patients with vasovagal syncope (10,19,20). This raises
the possibility of similar mechanisms of baroreflex dysfunction
in the two conditions.
Significance of the findings. Comparable findings have
been reported in patients with hypertensive LV hypertrophy, in
whom similar mechanisms may be invoked (21). We and other
investigators have also observed paradoxic vasodilation during
central blood volume unloading in patients with severe heart
failure (22–26). The mechanism in such patients may be
different, and we have proposed that abolition of pericardial
constraint and a diastolic–ventricular interaction may be im-
portant factors (27). None of the patients in the present study
had LV systolic dysfunction, and their exercise capacity was
only mildly limited.
We have previously reported exercise hypotension in ap-
proximately one-third of patients with HCM in association
with paradoxic forearm vasodilation (1,2). Abnormal exercise
blood pressure responses are associated with an increased risk
of sudden death (3), and we and other investigators have
proposed that hemodynamic collapse in the setting of an
electrically unstable and perhaps ischemically compromised
LV may be an important cause of sudden death (1,2,28,29).
However, ;50% of sudden deaths in patients with HCM
are not related to exercise (30). Although primary arrhythmias
may be responsible in at least some cases, our data suggest a
substrate for hypotension in settings other than exercise.
Indeed, a recent study demonstrated episodes of hypotension
occurring during everyday life, both during and unrelated to
exercise in patients with HCM (31). Central hypovolemia may
provoke paradoxic cardiopulmonary baroreceptor activation
with a consequent paradoxic fall in systemic vascular resistance
and hypotension. This may provide a rationale for the obser-
vation of a high rate of positive tilt-table tests in patients with
HCM (4). The association between abnormal forearm vascular
responses during LBNP and a clinical history of syncope (itself
a marker of increased risk of sudden death) is consistent with
such a mechanism. Hypotension during central volume unload-
ing might provide an additional or alternate trigger for malig-
nant arrhythmias in some patients with HCM, although this is
speculative.
Figure 2. Diagram of the baroreflexes and mechanoreflexes investi-
gated in this study. Cardiopulmonary baroreflexes are directly acti-
vated by a reduction in venous return (application of LBNP). Aortic
baroreflexes are activated by a reduction in arterial blood pressure
(BP). Afferent activity from both of these receptor groups traverses the
vagus nerve to the brain stem. Afferent activity from the carotid artery
baroreflexes (by application of positive [1ve] and negative [2ve]
pressure to the neck) traverses the glossopharyngeal nerve to the brain
stem. A normal response to these stimuli will produce an increase in
both heart rate and vasoconstriction in an attempt to increase venous
return.
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Study limitations. The patients and control subjects were
not exactly matched according to gender. There was a relative
excess of men in the control group. However, there was no
difference in cardiopulmonary, integrated or carotid artery
gains between male and female control subjects; we therefore
do not believe this bias is a significant limitation of the study.
Because central venous pressure fell equally in the patients
with HCM and the control subjects, we have concluded that
there was no evidence of exaggerated central hypovolemia in
patients. However, because pressure is only an indirect reflec-
tion of volume, we cannot be certain of volume changes.
Although cardioactive drugs were withdrawn at least five
half-lives before entry to the study, we accept that in the case
of beta-blockers, beta-receptor upregulation may be present at
this stage. However, excluding these patients from the analysis
did not significantly alter the results.
Conclusions. The present study suggests that LV (and
perhaps other cardiopulmonary) mechanoreceptors behave
abnormally during central blood volume unloading in patients
with HCM. This supports our previous suggestion that LV
mechanoreceptors may be implicated in exercise hypotension
in such patients (1,2). Hypotension occurring as a result of
such mechanisms, during exercise or postural stress, may
trigger a fatal arrhythmia. Consistent with this was our recent
observation, in a prospective study, of an association between
abnormal blood pressure responses during exercise and an
increased risk of sudden death (3).
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